Biotech GenEditBio Receives FDA Clearance of IND Application for Its Lead In Vivo Genome-Editing Program GEB-101 for TGFBI Corneal Dystrophy January 5, 2026
Biotech MarathonLS and Pacer Announce Strategic Separation into Two Independent Organizations January 3, 2026
Biotech Last day of trading in shares with pre-emptive rights in connection with rights issue January 2, 2026
Biotech Mabwell Announces First Patient Dosed in Phase II Trial of Anti-IL-11 Antibody for Pathological Scarring December 31, 2025
Biotech CARsgen Submits Dual IND Applications for Allogeneic BCMA CAR-T Product CT0596 December 29, 2025
Biotech Mabwell Receives IND Clearance for Novel Anti-ST2 Monoclonal Antibody 9MW1911 to Initiate Phase IIa Study December 28, 2025
Biotech From Follower to Force: China’s Biotech Sector Enters the Global Clinical Mainstream December 27, 2025
Search
Biotech
January 5, 2026
January 4, 2026
January 3, 2026
January 2, 2026
January 1, 2026
December 31, 2025
December 30, 2025
December 29, 2025
December 28, 2025
December 27, 2025
